HOME >> BIOLOGY >> NEWS
Fetal and prepubertal growth both programme cholesterol metabolism in adulthood

Birthweight, subsequent growth, and cholesterol metabolism in children 8-12 years old born preterm 2001;84: 212-17

The body's ability to process cholesterol as an adult is likely to be programmed by size at birth, shows research in Archives of Disease in Childhood. But just as important are the years between 8 and 12.

Birthweight, length of pregnancy, and weight at 18 months were measured in 412 boys and girls, all of whom were light for dates at birth. Blood fats, including indicators of cholesterol production and absorption, were subsequently measured when the children were aged 8 and 12.

Lower birthweight was associated with reduced cholesterol absorption in children born prematurely. Children who had more catching-up to do to achieve normal weight for age were significantly more likely to process cholesterol less efficiently, between the ages of 8 and 12.

The amount of body fat a child carried, rather than overall weight or current height, was associated with increased cholesterol production and lower cholesterol absorption. And that remained true even when the child was within the normal range of fatness, suggesting increasing fatness during childhood can affect the body's subsequent ability to process cholesterol.

The authors suggest that their findings indicate that cholesterol metabolism, and the attendant risk of heart disease in adulthood, are programmed not only during the womb, but also by growth up to puberty.


'"/>

Contact: BMA Press Office
pressoffice@bma.org.uk
44-0-207-383-6254
BMJ Specialty Journals
21-Feb-2001


Page: 1

Related biology news :

1. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
2. Fetal death, miscarriage linked to genetic mutation
3. CDC MMWR: Fetal Alcohol Syndrome and Cutaneous Anthrax in a Lab Worker
4. Fetal research first in USA
5. Fetal and birth complications increase mental illness risks
6. Functional Arteries Grown From Cells Using Novel System That Simulates Fetal Environment
7. Study Suggests Maternal Stress And Stress Hormones May Influence Fetal Brain Development In Utero
8. Maternal Anxiety May Affect Fetal Development
9. Fetal Surgery For Spina Bifida Still Under Investigation At VUMC
10. Fetal Growth Rate Affects Risk Of Heart Disease
11. Fetal Lead Exposure May Reduce Immunity

Post Your Comments:
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ... Monitor: North America Perimeter Security Systems Market" report to ... The North American perimeter security market is estimated to ... Although the U.S. market holds a larger share in this ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint ... http://photos.prnewswire.com/prnh/20130307/600769 Based ... 5S, Samsung introduces for the first time a fingerprint ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 GMO corn cases ... Syngenta, are in the process of being consolidated in a ... In Re: Syngenta AG MIR 162 Corn Litigation, MDL No. ... Kansas. , Management of the Syngenta GMO corn multidistrict litigation ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
Cached News: